Clinical Trial Update: REgulatory T Cell Therapy to Achieve Immunosuppression REduction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in kidney transplantation evaluating regulatory T cell therapy to reduce immunosuppression. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Regulatory T Cell Therapy to Achieve Immunosuppression Reduction

Snippet

Sponsor: Singulera Therapeutics Inc. | Conditions: Kidney Transplantation | Phase 2 | Status: RECRUITING